After studying chemistry in Marburg (Germany) and Edinburgh (UK) Daniel Garbe completed his Ph.D. at the Universities of Marburg and Dortmund (Germany). Since 2009, Dr. Garbe is employed at the Technical University of Munich. First, at the Chair of Chemistry of Biogenic Resources, he moved in 2011 to the novel Division of Industrial Biocatalysis. As a Project Manager for Biocatalysis, he was in charge of several projects dealing with the biotechnological conversion of biogenic waste streams into chemicals, pharmaceuticals or biofuels. From 2015 onwards, Dr. Garbe additionally serves as Scientific Director of the TUM-AlgaeTec Center. At this globally unique research facility, he is in charge of experiments to evaluate pilot scale algae cultivation with simulated climate scenarios. In 2018, Dr. Garbe was appointed to the position of leader of the group “Biocatalytic Reaction Systems” at the Werner Siemens-Chair of Synthetic Biotechnology. The research subject of the group is the development of new biocatalysts, which can be genetically modified microorganisms or designed, artificial cascades of enzymes from various origin. Selective modifications of metabolic pathways are planned on the basis of extended data collections gained by modern omics methods. Such tailored biocatalysts allow then for the conversion of biogenic resources and remainders thereof into high-value products with applications in the automotive, aviation, construction, chemistry or pharmaceutical industry.
After studying chemistry in Marburg (Germany) and Edinburgh (UK) Daniel Garbe completed his Ph.D. at the Universities of Marburg and Dortmund (Germany). Since 2009, Dr. Garbe is employed at the Technical University of Munich. First, at the Chair of Chemistry of Biogenic Resources, he moved in 2011 to the novel Division of Industrial Biocatalysis. As a Project Manager for Biocatalysis, he was in charge of several projects dealing with the biotechnological conversion of biogenic waste streams into chemicals, pharmaceuticals or biofuels. From 2015 onwards, Dr. Garbe additionally serves as Scientific Director of the TUM-AlgaeTec Center. At this globally unique research facility, he is in charge of experiments to evaluate pilot scale algae cultivation with simulated climate scenarios. In 2018, Dr. Garbe was appointed to the position of leader of the group “Biocatalytic Reaction Systems” at the Werner Siemens-Chair of Synthetic Biotechnology. The research subject of the group is the development of new biocatalysts, which can be genetically modified microorganisms or designed, artificial cascades of enzymes from various origin. Selective modifications of metabolic pathways are planned on the basis of extended data collections gained by modern omics methods. Such tailored biocatalysts allow then for the conversion of biogenic resources and remainders thereof into high-value products with applications in the automotive, aviation, construction, chemistry or pharmaceutical industry.